• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524INT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Infarction, Cerebral (1771); Encephalopathy (1833); Unspecified Infection (1930); Renal Failure (2041); Sepsis (2067)
Event Date 11/02/2020
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient had multi organ issues on (b)(6) 2020 after implantation.When attempting to wean patient from ventilator the patient was not awake nor responsive.Ct scan showed infract's in the brain.Electroencephalogram showed abnormal result suggestive of diffuse encephalopathy.The patient had oliguria, high creatinine levels.Nephrologist put patient on continuous renal replacement therapy on (b)(6) 2020 the patient was found to have high white blood cell count.Urine/endotracheal secretion culture showed candida tropicalls.Treatment included antibiotics and cytosorb filter.On 05nov2020, ct scan showed increased edema of infracts in the brain and a few hemorrhagic densities.Follow-up ct scan on 23nov2020 showed hypodense infract's.The patient is suffering from sepsis.Blood cultures revealed chryseobacterium indigenes.The patient is on ventilator, requiring dialysis for renal failure (the patient had pre-existing mild chronic kidney failure.Pre-implantation creatinine levels were 1.6).There was not much improvement in neurological function.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a direct relationship between heartmate 3 (hm3) left ventricular assist system (lvas), serial number (b)(6), and the reported multi organ failure, infection, sepsis, and stroke could not be conclusively determined through this evaluation.The patient later expired due to cardiac arrest on (b)(6) 2020 following a ct scan that showed subarachnoid/intraventricular hemorrhage (refer to manufacturer report number # 2916596-2020-06428).The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped with heartmate 3 left ventricular assist system (lvas) instructions for use (ifu).Multiple organ dysfunctions/failures, stroke, infection, and sepsis are listed as adverse events that may be associated with the use of heartmate 3 left ventricular assist system.Section 6 provides information regarding anticoagulation, including the recommended inr values.Care instructions in regard to preventing infection are provided in various sections of this ifu, including a section entitled "controlling infection." the heartmate 3 lvas patient handbook is also currently available.This handbook also contains information about preventing infection.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key11080256
MDR Text Key224025363
Report Number2916596-2020-06134
Device Sequence Number1
Product Code DSQ
Combination Product (y/n)N
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date01/11/2022
Device Model Number106524INT
Device Lot Number6935807
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received04/10/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-